Inflammatory biomarkers have a prognostic role in patients with metastatic castration‐resistant prostate cancer treated with Lutetium‐177–PSMA‐617Margo B. Gerke, Mehmet Asım Bilen, Yuan Liu et al.|Cancer|2026Cited by 2